Pricing Log in Create free account
Saturday 17 October 2026 Export REGN’s income statement to Excel — free account

Regeneron Pharmaceuticals, Inc.

REGN Healthcare Biotechnology

Regeneron Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, up 0.99% from fiscal 2024. In the quarter to June 2026, revenue grew 16.7%, EPS fell 4.68%, free cash flow fell 29.3% and total debt fell 26.6%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for three consecutive years.

790.74 5.60 −0.70%
Market cap
$82.0B
P/E
18.9×
Fwd P/E
16.5×
Dividend yield
0.47%
F-score
5/9
Altman Z
7.49
Beneish M
−2.53
Dividend safety
77/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Regeneron Pharmaceuticals, Inc. (REGN) Net margin

Alert me on Net margin

Regeneron Pharmaceuticals, Inc.'s net margin over the twelve months to 30 June 2026 was 27.9%, down 3.6 percentage points from fiscal 2025 (31.4%). Over the past ten years it has ranged from 15.5% (fiscal 2015) to 50.3% (fiscal 2021); the current reading is higher than 55% of that period. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.

Net margin, annual

Embed this chart

Annual newest first

Period Net margin Change (points)
FY2025 31.4% 0.34
FY2024 31.1% 0.93
FY2023 30.1% (5.50)
FY2022 35.6% (14.61)
FY2021 50.3% 8.90
FY2020 41.4% 9.09
FY2019 32.3% (15.24)
FY2018 47.5% 27.09
FY2017 20.4% 1.99
FY2016 18.4% 2.92

Quarterly newest first

Period Net margin Change (points)
Jun 2026 30.2% 10.06
Mar 2026 20.2% (1.57)
Dec 2025 21.7% (17.15)
Sep 2025 38.9% 1.03
42 more quarters

Against its own ten years

Low 15.5% High 50.3%
Ten-year median 31.4%
Current reading's percentile 26

Net margin against peers

Company Net margin
VRTX Vertex Pharmaceuticals Incorporated compare 35.0%
ARGX argenex SE compare 32.2%
RPRX Royalty Pharma PLC compare 32.0%
REGN Regeneron Pharmaceuticals, Inc. 27.9%
ALNY Alnylam Pharmaceuticals, Inc. compare 16.1%
ONC BeOne Medicines Ltd. - Sponsored ADR compare 10.7%
RVMD Revolution Medicines, Inc. compare 0.00%
MRNA Moderna, Inc. compare −141.4%
ROIV Roivant Sciences Ltd. compare −3,535.0%
Biotechnology industry median 0.00%
Healthcare sector median 0.00%
Market median 0.45%

What Net margin is

Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.

Net Income Allotted to Shareholders ÷ Revenue

The full definition of Net margin →

More on REGN